36 results
8-K
EX-99.1
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:22am
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release
PRE 14A
yqnwyudd43ma
8 Mar 24
Preliminary proxy
4:18pm
8-K
EX-99.1
slgzec0ve scwih
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
8-K
EX-10.1
skgc mxcqerxrai8
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
6kwmywufccs9nr th
18 Dec 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
EX-10.1
084o7hz
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
557rbyql
20 Dec 22
Regulation FD Disclosure
6:02am
8-K
EX-10.1
jvync1up6k
17 Oct 22
Entry into a Material Definitive Agreement
6:00am
8-K
y5n54vwh2h
11 Aug 22
Other Events
5:46pm
8-K
EX-1.1
oommjxl 6snyr9rrivay
11 Aug 22
Other Events
5:46pm
8-K
kdbsnii
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
8-K
h0nsunzs4b sf70hs
5 Jan 22
Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset
8:53am